EURL for public health in the field of "high risk, emerging and zoonotic bacterial pathogens"
- Funded by European Commission
- Total publications:0 publications
Grant number: 101194786
Grant search
Key facts
Disease
PlagueStart & end year
20252031Known Financial Commitments (USD)
$3,018,801.6Funder
European CommissionPrincipal Investigator
JACOB DanielaResearch Location
GermanyLead Research Institution
ROBERT KOCH-INSTITUTResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
As the human population is confronted with emerging and re-emerging infectious pathogens that can cause serious cross-border outbreaks, the EU Reference Laboratory (EURL) for Public Health in the field of "high risk, emerging and zoonotic bacterial pathogens", operating under the guidance of the ECDC, aims to strengthen national expert laboratories' capacities and to support a uniform surveillance, notification and reporting of diseases or the causative bacterial agents. By promoting good practice and alignment on diagnostics in the network member laboratories, an efficient, rapid and coordinated response according to the ECDC surveillance reporting system will be enhanced. This EURL contributes to the sustainable implementation of the Regulation (EU) 2022/2371 on serious cross-border threats to health and the repealing Decision No 1082/2013/EU, Article 15. To ensure efficiency and to avoid duplication of efforts, the EURL will actively collaborate with other EURLs and relevant initiatives within the European public health framework. This EURL covers emerging and zoonotic risk group (RG) 3 bacteria - Bacillus anthracis (anthrax), Yersinia pestis (plague), Francisella tularensis (tularemia), Brucella spp. (brucellosis), Burkholderia mallei (glanders), Burkholderia pseudomallei (melioidosis), Coxiella burnetii (Q fever), Rickettsia spp. (rickettsiosis) - as well as RG 2 bacteria - Borrelia spp. (borreliosis) and Leptospira spp. (leptospirosis). External quality assessment, sharing of reference materials, as well as appropriate training and twinning activities will ensure best laboratory responsiveness, diagnostics and bio-risk management, while fostering alignment of approaches on a voluntary basis. During outbreak situations and in case of unusual occurrences, the EURL will provide information (including pathogen characteristics), guidance, and support to the ECDC contributing to ECDC risk assessments.